Published in Surgery on December 01, 1990
Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy? Surgery (2015) 1.66
Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg (2004) 1.45
Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut (1998) 1.37
Primary hepatic carcinoid: a case report and literature review. World J Gastroenterol (2009) 1.28
Multimodal management of neuroendocrine liver metastases. HPB (Oxford) (2010) 1.21
Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg (2000) 1.20
Biology and treatment of metastatic gastrointestinal neuroendocrine tumors. Gastrointest Cancer Res (2008) 1.16
Surgical treatment of advanced-stage carcinoid tumors: lessons learned. Ann Surg (2005) 1.11
Liver transplantation for metastatic neuroendocrine tumors. Ann Surg (1997) 1.09
Liver resection for cancer. World J Gastroenterol (2001) 0.97
Surgical management of pancreatic neuroendocrine tumors. Surg Today (2011) 0.93
Liver transplantation for non-hepatocellular carcinoma malignancy. HPB (Oxford) (2007) 0.93
Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review. Int J Hepatol (2011) 0.90
Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor. Langenbecks Arch Surg (2009) 0.89
Surgical treatment and clinical outcome of nonfunctional pancreatic neuroendocrine tumors: a 14-year experience from one single center. Medicine (Baltimore) (2014) 0.86
Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour. Br J Cancer (2005) 0.86
Malignant nonfunctioning endocrine tumors of the pancreas: predictive factors for survival after surgical treatment. World J Surg (2007) 0.85
Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin. Br J Cancer (1999) 0.82
Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumours: outcome and prognostic predictors. HPB (Oxford) (2007) 0.82
A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors. Ann Oncol (2012) 0.80
Pancreatic neuroendocrine tumor accompanied with multiple liver metastases. World J Hepatol (2014) 0.79
Primary hepatic gastrinoma: Report of a case and review of literature. World J Gastrointest Pathophysiol (2011) 0.77
Whole body diffusion for metastatic disease assessment in neuroendocrine carcinomas: comparison with OctreoScan® in two cases. World J Surg Oncol (2012) 0.77
Surgical treatment of neuroendocrine liver metastases. Int J Hepatol (2012) 0.77
Curative versus palliative surgical resection of liver metastases in patients with neuroendocrine tumors: a meta-analysis of observational studies. Gland Surg (2014) 0.76
Practical management and treatment of pancreatic neuroendocrine tumors. Gland Surg (2014) 0.76
Hepatic parenchymal preserving technique in the management of diffuse bilateral neuroendocrine tumour liver metastases: a feasible approach. Can J Surg (2014) 0.75
The role of liver resections for metastases from lung carcinoma. HPB (Oxford) (2006) 0.75
Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas. World J Gastroenterol (2016) 0.75
Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies. J Am Coll Surg (2012) 0.75
Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med (1991) 7.21
Biliary tract cancers. N Engl J Med (1999) 6.36
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Surgical management of intussusception in the adult. Ann Surg (1981) 5.42
The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med (1989) 4.20
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol (1989) 4.03
Complications following pancreaticoduodenectomy. Current management. Arch Surg (1992) 3.94
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol (1989) 3.44
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst (2001) 3.37
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med (1985) 3.36
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation (1993) 3.29
Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab (2001) 3.19
Carcinoid tumors of the vermiform appendix. Cancer (1968) 3.07
Primary venous leiomyosarcoma: a rare but lethal disease. J Vasc Surg (1992) 3.05
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer (1991) 2.98
Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg (1992) 2.97
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95
Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet (1969) 2.94
Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med (1980) 2.72
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med (1986) 2.70
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med (1979) 2.63
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol (1998) 2.51
Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery (2001) 2.50
The physician's responsibility toward hopelessly ill patients. N Engl J Med (1984) 2.46
Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery (1987) 2.42
Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol (1983) 2.41
Surgical management of multiple polyposis. The problem of cancer in the retained bowel segment. Arch Surg (1970) 2.31
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. J Clin Oncol (1985) 2.26
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med (1997) 2.25
Survival after postoperative combination treatment of rectal cancer. N Engl J Med (1986) 2.24
Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet (1992) 2.15
Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg (1997) 2.13
Multiple primary malignant neoplasms: historical perspectives. Cancer (1977) 2.11
Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab (1999) 2.06
Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery (1992) 2.06
What prognostic factors are important in duodenal adenocarcinoma? Arch Surg (2000) 2.03
Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med (1987) 1.99
"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc (1995) 1.97
Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94
Controlled clinical studies of orally administered antiemetic drugs. Gastroenterology (1969) 1.92
Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg (1996) 1.88
Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med (1977) 1.84
Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg (1995) 1.82
The effect of measuring error on the results of therapeutic trials in advanced cancer. Cancer (1976) 1.81
Mesenteric lipodystrophy. Ann Intern Med (1974) 1.80
Treatment of the patient with adenocarcinoma of unknown origin. Cancer (1972) 1.79
Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res (1975) 1.75
Clinical management of advanced gastrointestinal cancer. Cancer (1975) 1.74
Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res (1990) 1.72
Neuroendocrine ampullary tumors: spectrum of disease including the first report of a neuroendocrine carcinoma of non-small cell type. Surgery (1994) 1.72
Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys (1993) 1.71
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Engl J Med (1981) 1.70
Anastomotic ulceration following subtotal and total pancreatectomy. Ann Surg (1979) 1.69
Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol (1999) 1.69
Long-term consequences of intraoperative spillage of bile and gallstones during laparoscopic cholecystectomy. J Gastrointest Surg (2006) 1.68
Replacement of the inferior vena cava for malignancy: an update. J Vasc Surg (2000) 1.66
Reexploration for symptomatic hematomas after cervical exploration. Surgery (2001) 1.66
Survival after surgical treatment for primary hyperparathyroidism. Surgery (1997) 1.66
Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg (2001) 1.64
Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol (2001) 1.63
Rectal cancer following colectomy for polyposis. Arch Surg (1980) 1.63
Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene (2003) 1.63
Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery (2000) 1.63
Spectrum and management of major complications of laparoscopic cholecystectomy. Am J Surg (1993) 1.59
Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med (2001) 1.58
Primary thyroid lymphoma. Semin Oncol (1999) 1.57
Chemotherapy of gastrointestinal cancer. N Engl J Med (1978) 1.56
Primary signet ring cell adenocarcinoma of the bladder. J Urol (1989) 1.55
Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg (1992) 1.53
Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer (1984) 1.52
The routine proctoscopic examination: a second look. Mayo Clin Proc (1966) 1.51
The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer (1986) 1.50
A comparative evaluation of marketed analgesic drugs. N Engl J Med (1972) 1.50
Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood (2000) 1.50
Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial. Int J Radiat Oncol Biol Phys (1996) 1.50
Radical resection for carcinoma of the ampulla of Vater. Arch Surg (1991) 1.49
Early gastric cancer. Br J Surg (1992) 1.49
Cholangiocarcinoma: diagnosis and evaluation of resectability by CT and sonography as procedures complementary to cholangiography. AJR Am J Roentgenol (1988) 1.48
Resection of hepatocellular carcinoma in patients without cirrhosis. Br J Surg (2011) 1.48
A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med (1982) 1.47
Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol (1984) 1.46
Diagnosis of corticotropin-producing bronchial carcinoid tumors causing Cushing's syndrome. Mayo Clin Proc (1990) 1.46
Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg (1990) 1.45
Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg (2001) 1.45
Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med (1993) 1.45
Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol (1984) 1.44
Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery (1988) 1.44